ANN ARBOR – Accuri Cytometers Monday announced the completion of a $4 million Series D financing round from current investors Fidelity Biosciences, Flagship Ventures, Baird Venture Partners and Arboretum Ventures, as well as the InvestMichigan! Program co-managed by Credit Suisse.
The money will be used to finance working and growth capital to support its C6 Flow Cytometer System, and its recently introduced CSampler. The C6 is designed to bring the power of flow
cytometry analysis to the laboratory of every life science researcher, and
the CSampler, an optional accessory that
adds user-friendly automation to the C6 system.
“With our first two products experiencing rapid market acceptance and
our European operations newly underway, we have secured additional capital
to build out our manufacturing and customer support capabilities in
Michigan and to continue to expand our commercial presence globally,” said
Jennifer Baird, CEO of Accuri. “In these challenging times, we are
gratified that all of our existing investors chose to participate in the
Series D financing at a higher valuation. We are especially pleased that
the InvestMichigan! Program, co-managed by Credit Suisse and championed by
Governor Jennifer Granholm, became a significant new investor.”
Explicitly designed for routine use by biomedical researchers in their
own labs, Accuri’s flow cytometer is a full-featured bench-top cell
analysis system that provides capabilities similar to industry-leading flow
cytometers in a more user-friendly format and at a fraction of the cost.
The newly introduced CSampler makes the Accuri C6 Flow Cytometer suitable
for high throughput applications, further extending its potential market
reach.
“Customer response in the Accuri C6 Flow Cytometer’s first year on the
market has exceeded our expectations for this revolutionary product,” said
Harry Wilcox, Partner at Flagship Ventures and a Director of Accuri.
“Current investors welcomed the opportunity to provide additional capital
to help fuel the company’s accelerating growth and we are pleased that a
new investor, the InvestMichigan! Program, participated in the financing.”
For more information, click on Accuricytometers.Com
a>>
